AAAAAA
Results:
1-9
|
Results: 9
Authors:
Guermazi, A
Brice, P
de Kerviler, E
Ferme, C
Hennequin, C
Meignin, V
Frija, J
Citation: A. Guermazi et al., Extranodal Hodgkin disease: Spectrum of disease, RADIOGRAPHI, 21(1), 2001, pp. 161-179
Authors:
Brice, P
Colin, P
Berger, F
de Kerviler, E
Divine, M
Bouaffia, F
Kerneis, Y
Blanc, M
Lepage, E
Ferme, C
Citation: P. Brice et al., Advanced Hodgkin disease with large mediastinal involvement can be treatedwith eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy - A study of 82 patients from the groupes d'Etudes des Lymphomes de ''adulte H89 Trial, CANCER, 92(3), 2001, pp. 453-459
Authors:
Ferme, C
Cosset, JM
Fervers, B
Sebban, C
Cutuli, B
Henry-Amar, M
Stines, J
Giammarile, F
Bey, P
Carella, AM
Philip, T
Citation: C. Ferme et al., Hodgkins disease, BR J CANC, 84, 2001, pp. 55-60
Authors:
Camilleri-Broet, S
Audouin, J
Ferme, C
Briere, J
Pulford, K
Gaulard, P
Divine, M
Macintyre, E
Delsol, G
Berger, F
Citation: S. Camilleri-broet et al., ALK is not expressed in Hodgkin disease, BLOOD, 97(6), 2001, pp. 1901-1902
Authors:
Ferme, C
Sebban, C
Hennequin, C
Divine, M
Lederlin, P
Gabarre, J
Ferrant, A
Caillot, D
Bordessoule, D
Brice, P
Moullet, I
Berger, F
Lepage, E
Citation: C. Ferme et al., Comparison of chemotherapy to radiotherapy as consolidation of complete orgood partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial, BLOOD, 95(7), 2000, pp. 2246-2252
Authors:
Brice, P
Divine, M
Simon, D
Coiffier, B
Leblond, V
Simon, M
Voilat, L
Devidas, A
Morschhauser, F
Rohrlich, P
Andre, M
Lepage, E
Ferme, C
Citation: P. Brice et al., Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD), ANN ONCOL, 10(12), 1999, pp. 1485-1488
Authors:
Ferme, C
Cosset, JM
Fervers, B
Sebban, C
Cutuli, B
Henry-Amar, M
Stines, J
Giammarile, F
Bey, P
Carella, AM
Philip, T
Citation: C. Ferme et al., Standards, options and recommendations for the management of patients withHodgkin's disease, PRESSE MED, 28(40), 1999, pp. 2233-2242
Authors:
Fitoussi, O
Simon, D
Brice, P
Makke, J
Scrobohaci, ML
Triki, TB
Hennequin, C
Ferme, C
Gisselbrecht, C
Citation: O. Fitoussi et al., Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma, BONE MAR TR, 24(7), 1999, pp. 747-755
Authors:
Flechtner, H
Ruffer, JU
Henry-Amar, M
Mellink, WAM
Sieber, M
Ferme, C
Eghbali, H
Josting, A
Diehl, V
Citation: H. Flechtner et al., Quality of life assessment in Hodgkin's disease: A new comprehensive approach - First experiences from the EORTC/GELA and GHSG trials, ANN ONCOL, 9, 1998, pp. 147-154
Risultati:
1-9
|